Evaluation of the MUREX*ICE HIV-1.O.2 capture enzyme immunoassay for early identification of HIV-1 seroreverting infants in a developing country. | Clin Diagn Virol;8(1): 1-8, 1997 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Evaluation of the MUREX*ICE HIV-1.O.2 capture enzyme immunoassay for early identification of HIV-1 seroreverting infants in a developing country.

Lyons, S F; Bowers, E T; McGillivray, G M; Blackburn, N K; Gray, G E.

Affiliation

Lyons SF; Department of Virology, University of the Witwatersrand, Johannesburg, South Africa. suel@niv.ac.za

Clin Diagn Virol ; 8(1): 1-8, 1997 May.

Article in En | MEDLINE | ID: mdl-9248653

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Immunoenzyme Techniques / HIV-1 Type of study: Diagnostic_studies / Evaluation_studies / Prognostic_studies Limits: Female / Humans / Infant Country/Region as subject: Africa Language: En Journal: Clin Diagn Virol Journal subject: VIROLOGIA Year: 1997 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Immunoenzyme Techniques / HIV-1 Type of study: Diagnostic_studies / Evaluation_studies / Prognostic_studies Limits: Female / Humans / Infant Country/Region as subject: Africa Language: En Journal: Clin Diagn Virol Journal subject: VIROLOGIA Year: 1997 Document type: Article Affiliation country: